Mast Cells as a Target—A Comprehensive Review of Recent Therapeutic Approaches
Open Access
Abstract
Mast cells (MCs) are the immune cells distributed throughout nearly all tissues, mainly in the skin, near blood vessels and lymph vessels, nerves, lungs, and the intestines. Although MCs are essential to the healthy immune response, their overactivity and pathological states can lead to numerous health hazards. The side effect of mast cell activity is usually caused by degranulation. It can be triggered by immunological factors, such as immunoglobulins, lymphocytes, or antigen–antibody complexes, and non-immune factors, such as radiation and pathogens. An intensive reaction of mast cells can even lead to anaphylaxis, one of the most life-threatening allergic reactions. What is more, mast cells play a role in the tumor microenvironment by modulating various events of tumor biology, such as cell proliferation and survival, angiogenesis, invasiveness, and metastasis. The mechanisms of the mast cell actions are still poorly understood, making it difficult to develop therapies for their pathological condition. This review focuses on the possible therapies targeting mast cell degranulation, anaphylaxis, and MC-derived tumors.Keywords
This publication has 99 references indexed in Scilit:
- The history of mast cell and basophil research – some lessons learnt from the last centuryAllergy, 2013
- Mast cells and inflammationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- Mast Cells in Tumor Microenvironment Promotes the In Vivo Growth of Pancreatic Ductal AdenocarcinomaClinical Cancer Research, 2011
- Mast Cell Targeting Hampers Prostate Adenocarcinoma Development but Promotes the Occurrence of Highly Malignant Neuroendocrine CancersCancer Research, 2011
- Epinephrine and its use in anaphylaxis: current issuesCurrent Opinion in Allergy and Clinical Immunology, 2010
- Mast cells and angiogenesis in gastric carcinomaInternational Journal of Experimental Pathology, 2010
- Crosstalk between Mast Cells and Pancreatic Cancer Cells Contributes to Pancreatic Tumor ProgressionClinical Cancer Research, 2010
- Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KITPLOS ONE, 2009
- The development of allergic inflammationNature, 2008
- Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancerBritish Journal of Cancer, 2007